Tian Zhang/utswmed.org
Jun 1, 2025, 04:14
Every Trial Gives Hope: Tian Zhang Shared Reflections Ahead of ASCO 2025
Tian Zhang, Associate Director of Clinical Research at the Simmons Comprehensive Cancer Center, shared a post on X:
“Traveling with mixed emotions to ASCO 25 this year. Celebrating science and the years of dedication, work, and patient contributions to cancer clinical trials. But science itself is under attack – defunding of preclinical discovery work will end up slowing our clinical advances.
At the center of next few days ASCO 25: our patients. And — if we face our humanity, ourselves – as we age and deal with cancer. Nothing harder in my clinic than telling a patient “there are no more treatment options”. Every trial gives hope and every new drug gives more time.
That’s what we all want with this brief time on earth – More time to be productive. More time to see the world. More time with loved ones.”
More posts featuring Tian Zhang on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jun 2, 2025, 15:40
Jun 2, 2025, 15:37
Jun 2, 2025, 15:20
Jun 2, 2025, 14:49
Jun 2, 2025, 13:13